These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 23724041)
21. YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection. Schiavon LL; Carvalho-Filho RJ; Narciso-Schiavon JL; Medina-Pestana JO; Lanzoni VP; Ferraz ML; Silva AE Scand J Gastroenterol; 2010 May; 45(5):615-22. PubMed ID: 20163287 [TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection. Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132 [TBL] [Abstract][Full Text] [Related]
23. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis. Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050 [TBL] [Abstract][Full Text] [Related]
24. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients. Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686 [TBL] [Abstract][Full Text] [Related]
25. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients. Toson EA; Shiha GE; Abdelgaleel AE Ann Hepatol; 2017 November-December,; 16(6):862-873. PubMed ID: 29055924 [TBL] [Abstract][Full Text] [Related]
27. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407 [TBL] [Abstract][Full Text] [Related]
28. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. Patel K; Lajoie A; Heaton S; Pianko S; Behling CA; Bylund D; Pockros PJ; Blatt LM; Conrad A; McHutchison JG J Gastroenterol Hepatol; 2003 Mar; 18(3):253-7. PubMed ID: 12603524 [TBL] [Abstract][Full Text] [Related]
29. Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults. Hawkins C; Christian B; Fabian E; Macha I; Gawile C; Mpangala S; Ulenga N; Thio CL; Ammerman LR; Mugusi F; Fawzi W; Green R; Murphy R J Acquir Immune Defic Syndr; 2017 Nov; 76(3):298-302. PubMed ID: 29016448 [TBL] [Abstract][Full Text] [Related]
30. The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection. Kramer JR; Kowalkowski MA; Duan Z; Chiao EY J Acquir Immune Defic Syndr; 2015 Apr; 68(4):456-62. PubMed ID: 25559606 [TBL] [Abstract][Full Text] [Related]
31. Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study. Gjærde LI; Shepherd L; Jablonowska E; Lazzarin A; Rougemont M; Darling K; Battegay M; Braun D; Martel-Laferriere V; Lundgren JD; Rockstroh JK; Gill J; Rauch A; Mocroft A; Klein MB; Peters L Clin Infect Dis; 2016 Sep; 63(6):821-829. PubMed ID: 27307505 [TBL] [Abstract][Full Text] [Related]